# Evaluating the Effect of CHanging EnfuvirtidE to Raltegravir in HIV Infected Subjects

> **NCT00529243** · PHASE3 · COMPLETED · sponsor: **Kaiser Permanente** · enrollment: 52 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** raltegravir

## Key facts

- **NCT ID:** NCT00529243
- **Lead sponsor:** Kaiser Permanente
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2008-07
- **Final completion:** 2009-09
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2018-08-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00529243

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00529243, "Evaluating the Effect of CHanging EnfuvirtidE to Raltegravir in HIV Infected Subjects". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT00529243. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*